Ohashi K - Search Results

1

Prognostic impact of TP53 mutation, monosomal karyotype, and prior myeloid disorder in nonremission acute myeloid leukemia at allo-HSCT.

Najima Y, Sadato D, Harada Y, Oboki K, Hirama C, Toya T, Doki N, Haraguchi K, Yoshifuji K, Akiyama M, Inamoto K, Igarashi A, Kobayashi T, Kakihana K, Okuyama Y, Sakamaki H, Harada H, Ohashi K. Najima Y, et al. Among authors: ohashi k. Bone Marrow Transplant. 2021 Feb;56(2):334-346. doi: 10.1038/s41409-020-01016-9. Epub 2020 Aug 5. Bone Marrow Transplant. 2021. PMID: 32760007

2

Mikoshiba M, Ohashi K, Takei N, Okuyama Y, Maeda Y, Hiruma K, Akiyama H, Fukuhara O, Takeshita A, Sakamaki H. Mikoshiba M, et al. Among authors: ohashi k. Int J Hematol. 2002 Jan;75(1):104-6. doi: 10.1007/BF02981989. Int J Hematol. 2002. PMID: 11843281 No abstract available.

3

Low-dose antithymocyte globulin for treatment of steroid-pulse-resistant acute graft-versus-host disease.

Ohashi K, Tanaka Y, Mori S, Okuyama Y, Hiruma K, Akiyama H, Sakamaki H. Ohashi K, et al. Int J Hematol. 2003 Jan;77(1):99-102. doi: 10.1007/BF02982612. Int J Hematol. 2003. PMID: 12568309 No abstract available.

4

Pyomyositis as a focus of infection in hematological disorders: a report of 3 cases.

Hayashi T, Nozaki M, Nonaka Y, Ohashi K, Sakamaki H, Nomura T. Hayashi T, et al. Among authors: ohashi k. Int J Hematol. 2003 Feb;77(2):171-4. doi: 10.1007/BF02983216. Int J Hematol. 2003. PMID: 12627853

5

[A long-lasting idiopathic factor V inhibitor].

Okoshi Y, Akiyama H, Inoue T, Koyama T, Kono N, Matsumura T, Mizuchi D, Mori S, Ohashi K, Sakamaki H. Okoshi Y, et al. Among authors: ohashi k. Rinsho Ketsueki. 2003 Jan;44(1):14-8. Rinsho Ketsueki. 2003. PMID: 12649832 Japanese.

6

Use of octreotide in the management of severe duodenal bleeding after unrelated-donor bone marrow transplantation.

Ohashi K, Sanaka M, Tanaka Y, Okuyama Y, Hiruma K, Akiyama H, Sakamaki H. Ohashi K, et al. Int J Hematol. 2003 Aug;78(2):176-7. doi: 10.1007/BF02983391. Int J Hematol. 2003. PMID: 12953817 No abstract available.

7

[Sustained remission of MDS overt leukemia associated with abrupt discontinuation of immunosuppression following relapse after the second course of allogeneic hematopoietic stem cell transplantation].

Ohashi K, Mikoshiba M, Tanaka Y, Okuyama Y, Hiruma K, Akiyama H, Sakamaki H. Ohashi K, et al. Rinsho Ketsueki. 2003 Nov;44(11):1085-9. Rinsho Ketsueki. 2003. PMID: 14689872 Japanese.

8

Calcineurin-inhibitor pain syndrome following haematopoietic stem cell transplantation.

Kida A, Ohashi K, Tanaka C, Kamata N, Akiyama H, Sakamaki H. Kida A, et al. Among authors: ohashi k. Br J Haematol. 2004 Aug;126(3):288. doi: 10.1111/j.1365-2141.2004.05066.x. Br J Haematol. 2004. PMID: 15257699 Free article. No abstract available.

9

Incapacitating lower limb pain syndrome in cord blood stem cell transplant recipients with calcineurin inhibitor.

Kida A, Ohashi K, Kobayashii T, Sakai M, Yamashita T, Akiyama H, Kishida S, Sakamaki H. Kida A, et al. Among authors: ohashi k. Pathol Oncol Res. 2004;10(4):204-6. doi: 10.1007/BF03033761. Epub 2004 Dec 27. Pathol Oncol Res. 2004. PMID: 15619640 Free article.

10

Cytogenetic abnormalities without evidence of relapse after treatment with imatinib and stem cell transplantation in a patient with Ph-positive ALL.

Sakai M, Ohashi K, Kobayashi T, Yamashita T, Akiyama H, Sakamaki H. Sakai M, et al. Among authors: ohashi k. Int J Hematol. 2005 Feb;81(2):171-3. doi: 10.1532/ijh97.04179. Int J Hematol. 2005. PMID: 15765789 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,642 results

Search Page

Filters